Real-world Experience of Sotrovimab in High-risk, Immunocompromised COVID-19 Patients.

Open Forum Infect Dis

Division of Infectious Diseases, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan, USA.

Published: July 2022

We completed a real-world analysis of 498 consecutive high-risk nonimmunocompromised and immunocompromised patients who received sotrovimab during the B.1.1.529 surge. Emergency department visits/hospitalizations and 30-day all-cause mortality between the 2 groups were similar. When administered early, sotrovimab is effective at preventing coronavirus disease 2019 progression in immunocompromised and nonimmunocompromised patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214182PMC
http://dx.doi.org/10.1093/ofid/ofac282DOI Listing

Publication Analysis

Top Keywords

real-world experience
4
experience sotrovimab
4
sotrovimab high-risk
4
high-risk immunocompromised
4
immunocompromised covid-19
4
covid-19 patients
4
patients completed
4
completed real-world
4
real-world analysis
4
analysis 498
4

Similar Publications

Background: Psychoeducation positively influences the psychological components of chronic low back pain (CLBP) in conventional treatments. The digitalization of health care has led to the discussion of virtual reality (VR) interventions. However, CLBP treatments in VR have some limitations due to full immersion.

View Article and Find Full Text PDF

Background: Telehomecare monitoring (TM) in patients with cancer is a complex intervention. Research shows variations in the benefits and challenges TM brings to equitable access to care, the therapeutic relationship, self-management, and practice transformation. Further investigation into these variations factors will improve implementation processes and produce effective outcomes.

View Article and Find Full Text PDF

Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective review.

J Am Acad Dermatol

January 2025

Dermatology Research Institute, Calgary, Alberta, Canada; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. Electronic address:

View Article and Find Full Text PDF

There have been significant advances in robotics, conversational AI, and spoken dialogue systems (SDSs) over the past few years, but we still do not find social robots in public spaces such as train stations, shopping malls, or hospital waiting rooms. In this paper, we argue that early-stage collaboration between robot designers and SDS researchers is crucial for creating social robots that can legitimately be used in real-world environments. We draw from our experiences running experiments with social robots, and the surrounding literature, to highlight recurring issues.

View Article and Find Full Text PDF

Architectural planning robot driven by unsupervised learning for space optimization.

Front Neurorobot

January 2025

Department of Architectural Engineering, Jinhua Polytecnich, Jinhua, Zhejiang, China.

Introduction: Space optimization in architectural planning is a crucial task for maximizing functionality and improving user experience in built environments. Traditional approaches often rely on manual planning or supervised learning techniques, which can be limited by the availability of labeled data and may not adapt well to complex spatial requirements.

Methods: To address these limitations, this paper presents a novel architectural planning robot driven by unsupervised learning for automatic space optimization.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!